WINT

Windtree Therapeutics, Inc.

1.22 USD

Last updated Dec 6, 05:34 UTC

Yesterday HIGH

$1.09

Yesterday LOW

$1

52w HIGH

$19.06

52w LOW

$0.86

EPS

-0.86

PE

-1.42

Next Earnings

Apr 1, 2024

Overview News Government Trades

Windtree Therapeutics, Inc. stock is up 15.09% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 28 December’s closed higher than November.

Windtree Therapeutics, Inc. focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trials for heart failure, and AEROSURF, an aerosolized KL4 surfactant.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

Warrington, United States Of America

Website

windtreetx.com

Benzinga Insights

Thu Apr 20, 2023

12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights

Thu Apr 20, 2023

Stocks That Hit 52-Week Lows On Thursday

During Thursday's session, 99 companies made new 52-week lows.
Lisa Levin

Thu Apr 20, 2023

Crude Oil Down 2%; AT&T Shares Plunge After Q1 Results

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Thursday. The Dow traded down 0.26% to 33,809.22 while the NASDAQ fell 0.43% to 12,104.71. The S&P 500, also fell, dropping, 0.45% to 4,135.70.
Lisa Levin

Thu Apr 20, 2023

Dow Tumbles 150 Points; Tesla Shares Drop After Q1 Results

U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.50% to 33,727.89 while the NASDAQ fell 0.49% to 12,097.82. The S&P 500, also fell, dropping, 0.58% to 4,130.33.
Adam Eckert

Thu Apr 20, 2023

Why Windtree Therapeutics Stock Is Tumbling Today

Windtree Therapeutics Inc (NASDAQ: WINT) shares are plunging in early trading Thursday after the company announced the pricing of an upsized publ
Benzinga Insights

Thu Apr 20, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Newsdesk

Thu Apr 20, 2023

Benzinga Pro's Top 5 Stocks To Watch For Thursday, April 20, 2023: GOOGL, XPEV, ANET, MGM, WINT

Alphabet (GOOGL) - The company will report quarterly results next week on Tuesday after market close. Alphabet will kick off (along with Microsoft (MSFT), also on Tuesday afternoon) big tech
Benzinga Newsdesk

Thu Apr 20, 2023

Windtree Therapeutics Has Priced Around 3.7M Common Shares And Warrants To Purchase Up To 3.7M Shares At A Combined Price Of $2.93, With Gross Proceeds Of $10.8M

The warrants have an exercise price of $2.93 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance. The warrants are fixed priced and do not contain any price
Lisa Levin

Thu Apr 20, 2023

Why MIND Technology Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Gainers
Lisa Levin

Wed Apr 19, 2023

Why Sonnet BioTherapeutics Shares Are Trading Lower By Around 13%; Here Are 20 Stocks Moving Premarket

Gainers Clearmind Medicine Inc. (NASDAQ: CMND) jumped 69.3% to $0.8480 in pre-market trading after dropping 12% on Tuesday. Clearmind Medicine recently announced a $3.5 million public offering priced at $0.78 per share.